Threshold of galactomannan antigenemia positivity for early diagnosis of invasive aspergillosis in neutropenic children

被引:25
作者
Dinand, Veronique [1 ]
Anjan, Madasu [1 ]
Oberoi, Jaswinder Kaur [2 ]
Khanna, Shilpi [2 ]
Yadav, Satya Prakash [1 ]
Wattal, Chand [2 ]
Sachdeva, Anupam [1 ]
机构
[1] Sir Ganga Ram Hosp, Dept Pediat, Pediat Hematol Oncol & Bone Marrow Transport Unit, New Delhi, India
[2] Sir Ganga Ram Hosp, Dept Clin Microbiol & Immunol, New Delhi, India
关键词
Aspergillosis; Child; Hematology/oncology; Infections in immunocompromised hosts; Neutropenia; Stem cell transplantation; LINKED-IMMUNOSORBENT-ASSAY; CELL TRANSPLANT RECIPIENTS; PROSPECTIVE CLINICAL-EVALUATION; POLYMERASE-CHAIN-REACTION; CANCER-PATIENTS; ENZYME-IMMUNOASSAY; IMMUNOCOMPROMISED PATIENTS; HEMATOLOGICAL PATIENTS; PEDIATRIC-PATIENTS; FUNGAL-INFECTIONS;
D O I
10.1016/j.jmii.2013.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Invasive aspergillosis (IA) is an important cause of morbidity and mortality in immunocompromised patients. Pediatric data on the accuracy and optimal cutoff of galactomannan antigen detection to diagnose IA is sparse and controversial. We evaluated the utility and optimal serum galactomannan assay (GA) cutoff in children. Methods: Children with febrile neutropenia due to malignancy, hematopoietic stem cell transplant, aplastic anemia, or congenital neutropenia, were prospectively included from 2007 to 2011. All new episodes of febrile neutropenia were recorded. In case of a previous diagnosis of IA, subsequent episodes were excluded. One to four GA were tested by enzyme immunoassay during each episode. Bronchoalveolar lavage and other relevant samples for mycological diagnosis, and computed tomography of chest/sinus were performed wherever appropriate. IA was classified as "proven", "probable", and "possible" as per the 2008 European Organisation for Research and Treatment of Cancer and Mycoses Study Group Guidelines. The optimal cutoff value was determined using receiver operating characteristic curves in episode-wise analysis. Results: There were 145 patients with 211 febrile episodes included: hematopoietic stem cell transplant (n = 15), oncological (n = 113), and hematological disorders (n = 17). Forty-five children (31.0%) developed IA (5 proven, 15 probable, and 25 possible). Cutoff value of single GA > 0.7 for proven/probable/possible IA offered the best combination of sensitivity (82.2%)/ specificity (82.5%), and 94.4% negative predictive value. Two consecutive positive GA >= 0.7 had a sensitivity/specificity of 75.0%/91.0%. Index GA >= 1.9 was associated with significantly higher mortality in children with IA and overall. Conclusion: Serum GA is sensitive to diagnose IA in pediatric patients with excellent negative predictive value at an optimal cutoff of >= 0.7. Considering two consecutive values >= 0.7 increases specificity to 91.0%. Copyright (C) 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:66 / 73
页数:8
相关论文
共 25 条
[1]   Detection of Aspergillus galactomannan antigen in foods and antibiotics [J].
Ansorg, R ;
van den Boom, R ;
Rath, PM .
MYCOSES, 1997, 40 (9-10) :353-357
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   Diagnostic potential of nested PCR, galactomannan EIA, and Beta-D-glucan for invasive aspergillosis in pediatric patients [J].
Badiee, Parisa ;
Alborzi, Abdolvahab ;
Karimi, Mahammad ;
Pourabbas, Bahman ;
Haddadi, Pedram ;
Mardaneh, Jalal ;
Moieni, Mahsa .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2012, 6 (04) :352-357
[4]   Prospective clinical evaluation of a LightCycler™-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients [J].
Buchheidt, D ;
Hummel, M ;
Schleiermacher, D ;
Spiess, B ;
Schwerdtfeger, R ;
Cornely, OA ;
Wilhelm, S ;
Reuter, S ;
Kern, W ;
Südhoff, T ;
Mörz, H ;
Hehlmann, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (02) :196-202
[5]   Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients [J].
Choi, Soo-Han ;
Kang, Eun-Suk ;
Eo, Hong ;
Yoo, So-Young ;
Kim, Ji Hye ;
Yoo, Keon Hee ;
Sung, Ki Woong ;
Koo, Hong Hoe ;
Kim, Yae-Jean .
PEDIATRIC BLOOD & CANCER, 2013, 60 (02) :316-322
[6]   Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [J].
De Pauw, Ben ;
Walsh, Thomas J. ;
Donnelly, J. Peter ;
Stevens, David A. ;
Edwards, John E. ;
Calandra, Thierry ;
Pappas, Peter G. ;
Maertens, Johan ;
Lortholary, Olivier ;
Kauffman, Carol A. ;
Denning, David W. ;
Patterson, Thomas F. ;
Maschmeyer, Georg ;
Bille, Jacques ;
Dismukes, William E. ;
Herbrecht, Raoul ;
Hope, William W. ;
Kibbler, Christopher C. ;
Kullberg, Bart Jan ;
Marr, Kieren A. ;
Munoz, Patricia ;
Odds, Frank C. ;
Perfect, John R. ;
Restrepo, Angela ;
Ruhnke, Markus ;
Segal, Brahm H. ;
Sobel, Jack D. ;
Sorrell, Tania C. ;
Viscoli, Claudio ;
Wingard, John R. ;
Zaoutis, Theoklis ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1813-1821
[7]   An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome [J].
Denning, DW ;
Marinus, A ;
Cohen, J ;
Spence, D ;
Herbrecht, R ;
Pagano, L ;
Kibbler, C ;
Kcrmery, V ;
Offner, F ;
Cordonnier, C ;
Jehn, U ;
Ellis, M ;
Collette, L ;
Sylvester, R .
JOURNAL OF INFECTION, 1998, 37 (02) :173-180
[8]   Invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :781-803
[9]   Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia [J].
Halliday, C ;
Hoile, R ;
Sorrell, T ;
James, G ;
Yadav, S ;
Shaw, P ;
Bleakley, M ;
Bradstock, K ;
Chen, S .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (04) :478-486
[10]   Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients [J].
Herbrecht, R ;
Letscher-Bru, V ;
Oprea, C ;
Lioure, B ;
Waller, J ;
Campos, F ;
Villard, O ;
Liu, KL ;
Natarajan-Amé, S ;
Lutz, P ;
Dufour, P ;
Bergerat, JP ;
Candolfi, E .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1898-1906